Not logged in.png)
Share.png)
SaveShare Save Share Save Share Save Share Save Lipid metabolic reprograming: the unsung hero in breast cancer progression and tumor microenvironment
Wan, Mengting; Pan, Shuaikang; Shan, Benjie; Diao, Haizhou; Jin, Hongwei; Wang, Ziqi; Wang, Wei; Han, Shuya; Liu, Wan; He, Jiaying; Zheng, Zihan; Pan, Yueyin; Han, Xinghua; Zhang, Jinguo Share Save A plain language summary of results from the TORCHLIGHT trial of toripalimab plus chemotherapy for metastatic or recurrent triple-negative breast cancerJiang, Zefei; Ouyang, Quchang; Sun, Tao; Zhang, Qingyuan; Teng, Yuee; Cui, Jiuwei; Wang, Haibo; Yin, Yongmei; Wang, Xiaojia; Zhou, Xin; Wang, Yongsheng; Sun, Gang; Wang, Jingfen; Zhang, Lili; Yang, Jin; Qian, Jun; Yan, Min; Liu, Xinlan; Yi, Tienan; Cheng, Ying; Li, Man; Zang, Aimin; Wang, Shusen; Wang, Chuan; Wu, Xinhong; Cheng, Jing; Li, Hui; Lin, Ying; Geng, Cuizhi; Gu, Kangsheng; Xie, Chunwei; Xiong, Huihua; Wu, Xiaohong; Yang, Junlan; Li, Qingshan; Chen, Yiding; Li, Fanfan; Zhang, Anqin; Zhang, Yongqiang; Wu, Yudong; Nie, Jianyun; Liu, Qiang; Wang, Kun; Mo, Xueli; Chen, Lilin; Pan, Yueyin; Fu, Peifen; Zhang, Helong; Pang, Danmei; Sheng, Yuan; Han, Yunwei; Wang, Hongxia; Cang, Shundong; Luo, Xianming; Yu, Wenbo; Deng, Rong; Yang, Chaoqiang; Keegan, Patricia Share Save A nanozyme-based drug delivery system to amplify ferroptosis via MET inhibition and photodynamic therapyXu, Mengran; Lai, Fuxuan; Liu, Hu; Hu, Delin; Sun, Yexiang; Li, Fenfen; Sun, Min; Lv, Na; Qiu, Bensheng; Pan, Yueyin; Hu, Yi Share Save Phase 2 dose-ranging study to evaluate the efficacy fi cacy and safety of liposomal irinotecan (LY01610) as a second-line treatment for patients with relapsed small cell lung cancerXing, Puyuan; Wang, Shanbing; Bi, Minghong; Liu, Yong; Zeng, Jia; Wang, Xicheng; Xiao, Ke; Li, Weidong; Guo, Jun; Wang, Pu; Pan, Yueyin; Ren, Biyong; Gao, Emei; Zhang, Lei; Wang, Yingchun; Gan, Tianyi; Cheng, Guang; Shi, Yuankai Share Save Share Save Share Save Myeloid PTEN loss affects the therapeutic response by promoting stress granule assembly and impairing phagocytosis by macrophages in breast cancerLi, Yan; Xu, Chao; Qian, Xiaojun; Wang, Gang; Han, Chaoqiang; Hua, Hui; Dong, Menghao; Chen, Jian; Yu, Haiyang; Zhang, Rutong; Feng, Xiaoxi; Yang, Zhenye; Pan, Yueyin Share Save Fruquintinib plus paclitaxel versus placebo plus paclitaxel for gastric or gastroesophageal junction adenocarcinoma: the randomized phase 3 FRUTIGA trialWang, Feng; Shen, Lin; Guo, Weijian; Liu, Tianshu; Li, Jin; Qin, Shukui; Bai, Yuxian; Chen, Zhendong; Wang, Jufeng; Pan, Yueyin; Shu, Yongqian; Zhao, Fuyou; Cheng, Ying; Ye, Feng; Gu, Kangsheng; Zhang, Tao; Pan, Hongming; Zhong, Haijun; Zhou, Fuxiang; Qin, Yanru; Yang, Lei; Mao, Weidong; Li, Qiu; Dai, Wenxiang; Li, Wei; Wang, Shubin; Tang, Yong; Ma, Dong; Yin, Xianli; Deng, Yanhong; Yuan, Ying; Li, Man; Hu, Wenwei; Chen, Donghui; Li, Guoxin; Liu, Qiqi; Tan, Panfeng; Fan, Songhua; Shi, Michael; Su, Weiguo; Xu, Rui-Hua Share Save Effects of sintilimab plus chemotherapy as fi rst-line treatment on health-related quality of life in patients with advanced esophageal squamous cell carcinoma: results from the randomized phase 3 ORIENT-15 studyLu, Zhihao; Kong, Li; Wang, Buhai; Wang, Junye; Liu, Lianke; Shu, Yongqian; Yang, Lei; Sun, Guogui; Cao, Guochun; Ji, Yinghua; Cui, Tongjian; Liu, Hu; Qiu, Wensheng; Li, Na; Li, Gaofeng; Luo, Hui; Hou, Xinfang; Zhang, Yanqiao; Yue, Wenbin; Xue, Liying; Liu, Zheng; Pan, Yueyin; Gao, Shegan; Wang, Xiuwen; Pan, Zhanyu; Zhang, Shuqun; Lin, Gen; Xie, Yanru; Gu, Kangsheng; Ren, Tiejun; Li, Weidong; Li, Tao; Wang, Shoufeng; He, Wei; Fan, Yun; Liang, Jun; Xia, Bing; Zhao, Li; Wang, Shuxuan; Shen, Lin Share Save Share Save First-line penpulimab combined with paclitaxel and carboplatin for metastatic squamous non-small-cell lung cancer in China (AK105-302): a multicentre, randomised, double-blind, placebo-controlled phase 3 clinical trialZhong, Hua; Sun, Shengjie; Chen, Jianhua; Wang, Ziping; Zhao, Yanqiu; Zhang, Guojun; Chen, Gongyan; Zhou, Ming; Zhou, Jianying; Du, Yingying; Wu, Lin; Xu, Zhi; Mei, Xiaodong; Zhang, Weidong; He, Jingdong; Cui, Jiuwei; Zhang, Zhihong; Luo, Hui; Liu, Weiyou; Sun, Meili; Wu, Jingxun; Shen, Yongchun; Zhang, Shucai; Yang, Nong; Wang, Mengzhao; Lu, Junguo; Li, Kai; Yao, Weirong; Sun, Qian; Yue, Hongmei; Wang, Lin; Ye, Sheng; Li, Bin; Zhuang, Xibin; Pan, Yueyin; Zhang, Min; Shu, Yongqian; He, Zhiyong; Pan, Lei; Ling, Yang; Liu, Shengming; Zhang, Qi; Jiao, Shunchang; Han, Baohui Share Save Efficacy of YK-029A, a novel EGFR TKI, in advanced NSCLC patients with acquired T790M mutationWan, Rui; Chau, Yi Fung; Zhao, Jun; Liu, Zhe; Zhao, Mingfang; Zhao, Yanqiu; Dai, Xiumei; Pan, Yueyin; Zhang, Zhihong; Yao, Yu; Yang, Kunyu; Wu, Lin; Xie, Yanyan; Chen, Bi; Yang, Yixuan; Guo, Yongqi; Wang, Jie; Duan, Jianchun Share Save Distinct fibroblast subpopulations associated with bone, brain or intrapulmonary metastasis in advanced non-small-cell lung cancerXu, Ke; Wang, Hao; Zou, Yu-Xia; Zhang, Huan-Huan; Wang, Yue-Nan; Ren, Xue-Ru; Wang, Han-Qi; Xu, Ye-Hong; Li, Jia-Jun; Tang, Hao; He, Cheng; Wei, Song; Tian, Tian; Li, Lai-Lin; Zhou, Hui; Xu, Lin-Juan; Fang, Jing-Wen; Guo, Chuang; Yang, Jia-Xuan; Zhou, You-Yang; Zhang, Zhi-Hong; Pan, Yue-Yin Share Save Share Save Sunvozertinib for patients in China with platinum-pretreated locally advanced or metastatic non-small-cell lung cancer and EGFR exon 20 insertion mutation (WU-KONG6): single-arm open-label, multicentre, phase 2 trialWang, Mengzhao; Fan, Yun; Sun, Meili; Wang, Yongsheng; Zhao, Yanqiu; Jin, Bo; Hu, Ying; Han, Zhigang; Song, Xia; Liu, Anwen; Tang, Kejing; Ding, Cuimin; Liang, Li; Wu, Lin; Gao, Junzhen; Wang, Jianghong; Cheng, Ying; Zhou, Jianying; He, Yong; Dong, Xiaorong; Yao, Yu; Yu, Yan; Wang, Huijie; Sun, Si; Huang, Jianan; Fang, Jian; Li, Wen; Wang, Lin; Ren, Xiubao; Zhou, Chengzhi; Hu, Yanping; Zhao, Dahai; Yang, Runxiang; Xu, Fei; Huang, Yijiang; Pan, Yueyin; Cui, Jiuwei; Xu, Yan; Yang, Zhenfan; Shi, Yuankai Share Save 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
